rs1352053477
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BS2
The NM_001370259.2(MEN1):c.1397A>T(p.Glu466Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000107 in 1,596,148 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001370259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.1397A>T | p.Glu466Val | missense_variant | Exon 10 of 10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152072Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1444076Hom.: 0 Cov.: 43 AF XY: 0.00000696 AC XY: 5AN XY: 718606
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152072Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74286
ClinVar
Submissions by phenotype
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 11274402, 11526476) -
The MEN1 c.1397A>T; p.Glu466Val variant (rs1352053477), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 457293). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glutamate at codon 466 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.484). Due to limited information, the clinical significance of the p.Glu466Val variant is uncertain at this time. -
Multiple endocrine neoplasia, type 1 Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 466 of the MEN1 protein (p.Glu466Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MEN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 457293). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MEN1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.E466V variant (also known as c.1397A>T), located in coding exon 9 of the MEN1 gene, results from an A to T substitution at nucleotide position 1397. The glutamic acid at codon 466 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at